Dissemin is shutting down on January 1st, 2025

Published in

Wiley, Clinical Transplantation, 7(35), 2021

DOI: 10.1111/ctr.14317

Links

Tools

Export citation

Search in Google Scholar

Obesity is a risk factor for progression to kidney transplant waitlisting after liver transplantation

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

AbstractBackgroundNon‐alcoholic steatohepatitis has emerged as a leading cause of cirrhosis, and obesity‐associated comorbidities, including renal disease, have increased in prevalence. Obesity predisposes the kidney to hyperfiltration injury, potentially impairing acute kidney injury recovery. Identification of patients at risk for renal dysfunction is impeded by poor performance of renal function estimating equations among cirrhotics. To better understand obesity among cirrhotics and renal disease progression, we examined likelihood of kidney transplantation (KT) waitlisting after liver transplant alone (LTA) by obesity class.Methods68 607 LTA recipients were identified in SRTR (2005–2018). Fine and Gray competing risks models were used to analyze likelihood of KT waitlisting.Results27.4% of recipients were obese (BMI ≥ 30 kg/m2) and were 10% more likely to require KT waitlisting (aHR: 1.10, 95%CI: 1.01–1.20). Risk was highest among recipients with Classes II and III obesity (BMI: ≥35 kg/m2) (aHR: 1.37, 95%CI: 1.17–1.56). Moreover, recipients with Classes II and III obesity were 57% more likely to require KT waitlisting within one year post‐LTA (aHR: 1.57, 95%CI: 1.18–2.10) compared to non‐obese recipients.DiscussionThese findings suggest obesity was a risk factor for renal recovery failure and/or renal disease progression post‐LTA and may confound identification of renal dysfunction and/or prediction of renal recovery among cirrhotics.